These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 26960771)

  • 1. [Role/function of protease-activated receptor 2 on vascular endothelium in metabolic syndrome].
    Maruyama K; McGuire JJ; Shinozuka K; Kagota S
    Nihon Yakurigaku Zasshi; 2016 Mar; 147(3):135-8. PubMed ID: 26960771
    [No Abstract]   [Full Text] [Related]  

  • 2. Protease-activated receptor 2 and bradykinin-mediated vasodilation in the cerebral arteries of stroke-prone rats.
    Smeda JS; McGuire JJ; Daneshtalab N
    Peptides; 2010 Feb; 31(2):227-37. PubMed ID: 19954757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progression of Time-Dependent Changes to the Mechanisms of Vasodilation by Protease-Activated Receptor 2 in Metabolic Syndrome.
    Maruyama K; McGuire JJ; Kagota S
    Biol Pharm Bull; 2017; 40(12):2039-2044. PubMed ID: 29199228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced Nitric Oxide Synthase Activation via Protease-Activated Receptor 2 Is Involved in the Preserved Vasodilation in Aortas from Metabolic Syndrome Rats.
    Maruyama K; Kagota S; McGuire JJ; Wakuda H; Yoshikawa N; Nakamura K; Shinozuka K
    J Vasc Res; 2015; 52(4):232-43. PubMed ID: 26760532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms underlying enhanced vasorelaxant response to protease-activated receptor 2-activating peptide in type 2 diabetic Goto-Kakizaki rat mesenteric artery.
    Matsumoto T; Ishida K; Taguchi K; Kobayashi T; Kamata K
    Peptides; 2009 Sep; 30(9):1729-34. PubMed ID: 19540892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of chronic in-vivo treatments with protease-activated receptor 2 agonist on endothelium function and blood pressures in mice.
    Hughes KH; Wijekoon EP; Valcour JE; Chia EW; McGuire JJ
    Can J Physiol Pharmacol; 2013 Apr; 91(4):295-305. PubMed ID: 23627841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization and Functions of Protease-Activated Receptor 2 in Obesity, Diabetes, and Metabolic Syndrome: A Systematic Review.
    Kagota S; Maruyama K; McGuire JJ
    Biomed Res Int; 2016; 2016():3130496. PubMed ID: 27006943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of proteinase activated receptor-2 in the vascular response to sphingosine 1-phosphate.
    Roviezzo F; De Angelis A; De Gruttola L; Bertolino A; Sullo N; Brancaleone V; Bucci M; De Palma R; Urbanek K; D'Agostino B; Ianaro A; Sorrentino R; Cirino G
    Clin Sci (Lond); 2014 Apr; 126(8):545-56. PubMed ID: 24131465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Possible effect of E-selectine on structure and function of arterial vessels in patients with metabolic syndrome].
    Voloshyna OO; Lyzohub VH; Romanenko IM
    Lik Sprava; 2007; (5-6):28-32. PubMed ID: 18416160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct roles for PAR1- and PAR2-mediated vasomotor modulation in human arterial and venous conduits.
    Ballerio R; Brambilla M; Colnago D; Parolari A; Agrifoglio M; Camera M; Tremoli E; Mussoni L
    J Thromb Haemost; 2007 Jan; 5(1):174-80. PubMed ID: 17059415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptor-activating peptides for PAR-1 and PAR-2 relax rat gastric artery via multiple mechanisms.
    Kawabata A; Nakaya Y; Ishiki T; Kubo S; Kuroda R; Sekiguchi F; Kawao N; Nishikawa H; Kawai K
    Life Sci; 2004 Oct; 75(22):2689-702. PubMed ID: 15369704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of PAR-2 elicits NO-dependent and CGRP-independent dilation of the dural artery.
    Bhatt DK; Ploug KB; Ramachandran R; Olesen J; Gupta S
    Headache; 2010 Jun; 50(6):1017-30. PubMed ID: 20487037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Biology of the vascular wall and metabolic syndrome].
    Esteller Pérez A
    Nutr Hosp; 2005; 20(1):5-17. PubMed ID: 15762415
    [No Abstract]   [Full Text] [Related]  

  • 14. Coronary vascular dysfunction promoted by oxidative-nitrative stress in SHRSP.Z-Lepr(fa) /IzmDmcr rats with metabolic syndrome.
    Kagota S; Fukushima K; Umetani K; Tada Y; Nejime N; Nakamura K; Mori H; Sugimura K; Kunitomo M; Shinozuka K
    Clin Exp Pharmacol Physiol; 2010 Nov; 37(11):1035-43. PubMed ID: 20659132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelium-dependent and -independent responses to protease-activated receptor-2 (PAR-2) activation in mouse isolated renal arteries.
    Moffatt JD; Cocks TM
    Br J Pharmacol; 1998 Oct; 125(4):591-4. PubMed ID: 9831889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone Morphogenic Protein 4-Smad-Induced Upregulation of Platelet-Derived Growth Factor AA Impairs Endothelial Function.
    Hu W; Zhang Y; Wang L; Lau CW; Xu J; Luo JY; Gou L; Yao X; Chen ZY; Ma RC; Tian XY; Huang Y
    Arterioscler Thromb Vasc Biol; 2016 Mar; 36(3):553-60. PubMed ID: 26769046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potent and metabolically stable agonists for protease-activated receptor-2: evaluation of activity in multiple assay systems in vitro and in vivo.
    Kawabata A; Kanke T; Yonezawa D; Ishiki T; Saka M; Kabeya M; Sekiguchi F; Kubo S; Kuroda R; Iwaki M; Katsura K; Plevin R
    J Pharmacol Exp Ther; 2004 Jun; 309(3):1098-107. PubMed ID: 14976227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Omega-3 PUFAs improved endothelial function and arterial stiffness with a parallel antiinflammatory effect in adults with metabolic syndrome.
    Tousoulis D; Plastiras A; Siasos G; Oikonomou E; Verveniotis A; Kokkou E; Maniatis K; Gouliopoulos N; Miliou A; Paraskevopoulos T; Stefanadis C
    Atherosclerosis; 2014 Jan; 232(1):10-6. PubMed ID: 24401211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial function and arterial stiffness in normotensive normoglycemic first-degree relatives of diabetic patients are independent of the metabolic syndrome.
    Scuteri A; Tesauro M; Rizza S; Iantorno M; Federici M; Lauro D; Campia U; Turriziani M; Fusco A; Cocciolillo G; Lauro R
    Nutr Metab Cardiovasc Dis; 2008 Jun; 18(5):349-56. PubMed ID: 17935958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycaemic variability using continuous glucose monitoring and endothelial function in the metabolic syndrome and in Type 2 diabetes.
    Buscemi S; Re A; Batsis JA; Arnone M; Mattina A; Cerasola G; Verga S
    Diabet Med; 2010 Aug; 27(8):872-8. PubMed ID: 20653743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.